Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

721 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients.
Yamamoto E, Fujisawa S, Hagihara M, Tanaka M, Fujimaki K, Kishimoto K, Hashimoto C, Itabashi M, Ishibashi D, Nakajima Y, Tachibana T, Kawasaki R, Kuwabara H, Koharazawa H, Yamazaki E, Tomita N, Sakai R, Fujita H, Kanamori H, Ishigatsubo Y. Yamamoto E, et al. Among authors: kishimoto k. Cancer Sci. 2014 Jan;105(1):105-9. doi: 10.1111/cas.12321. Epub 2014 Jan 23. Cancer Sci. 2014. PMID: 24450386 Free PMC article.
R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma.
Tomita N, Takasaki H, Miyashita K, Fujisawa S, Ogusa E, Matsuura S, Kishimoto K, Numata A, Fujita A, Ohshima R, Kuwabara H, Hagihara M, Hashimoto C, Takemura S, Koharazawa H, Yamazaki E, Fujimaki K, Taguchi J, Sakai R, Ishigatsubo Y. Tomita N, et al. Among authors: kishimoto k. Br J Haematol. 2013 May;161(3):383-8. doi: 10.1111/bjh.12281. Epub 2013 Feb 25. Br J Haematol. 2013. PMID: 23432318 Free article.
Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation.
Motohashi K, Suzuki T, Kishimoto K, Numata A, Nakajima Y, Tachibana T, Ohshima R, Kuwabara H, Tanaka M, Tomita N, Ishigatsubo Y, Fujisawa S. Motohashi K, et al. Among authors: kishimoto k. Int J Hematol. 2013 Aug;98(2):258-60. doi: 10.1007/s12185-013-1387-8. Epub 2013 Jun 26. Int J Hematol. 2013. PMID: 23801427
Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Watanabe R, Tomita N, Kishimoto K, Koyama S, Ogusa E, Ishii Y, Miyashita K, Matsuura S, Fujisawa S, Hattori Y, Takasaki H, Fujita A, Ohshima R, Kuwabara H, Hashimoto C, Fujimaki K, Sakai R, Ishigatsubo Y. Watanabe R, et al. Among authors: kishimoto k. Leuk Res. 2013 Oct;37(10):1208-12. doi: 10.1016/j.leukres.2013.07.015. Epub 2013 Aug 5. Leuk Res. 2013. PMID: 23927994
Standard R-CHOP therapy in follicular lymphoma and diffuse large B-cell lymphoma.
Tomita N, Takasaki H, Fujisawa S, Miyashita K, Ogusa E, Kishimoto K, Matsuura S, Sakai R, Koharazawa H, Yamamoto W, Fujimaki K, Fujita H, Ishii Y, Taguchi J, Kuwabara H, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: kishimoto k. J Clin Exp Hematop. 2013;53(2):121-5. doi: 10.3960/jslrt.53.121. J Clin Exp Hematop. 2013. PMID: 23995108 Free article.
Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.
Tomita N, Takasaki H, Ishiyama Y, Kishimoto K, Ishibashi D, Koyama S, Ishii Y, Takahashi H, Numata A, Watanabe R, Tachibana T, Ohshima R, Hagihara M, Hashimoto C, Takemura S, Taguchi J, Fujimaki K, Sakai R, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: kishimoto k. Leuk Lymphoma. 2015 Mar;56(3):725-9. doi: 10.3109/10428194.2014.931953. Epub 2014 Aug 6. Leuk Lymphoma. 2015. PMID: 24913502
Successful pregnancy and delivery via in vitro fertilization with cryopreserved and thawed embryo transfer in an acute myeloid leukemia patient after allogeneic bone marrow transplantation.
Nakajima Y, Kuwabara H, Kishimoto K, Numata A, Motohashi K, Tachibana T, Tanaka M, Yamashita N, Ishigatsubo Y, Fujisawa S. Nakajima Y, et al. Among authors: kishimoto k. Int J Hematol. 2015 Apr;101(4):417-20. doi: 10.1007/s12185-014-1709-5. Epub 2014 Nov 28. Int J Hematol. 2015. PMID: 25430084
Dissemination pattern of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.
Ishii Y, Tomita N, Suzuki T, Ishiyama Y, Kishimoto K, Yamamoto E, Koyama S, Hattori Y, Nakajima Y, Motohashi K, Takasaki H, Kawasaki R, Hashimoto C, Takemura S, Fujimaki K, Fujita H, Sakai R, Fujisawa S, Motomura S, Ishigatsubo Y. Ishii Y, et al. Among authors: kishimoto k. Leuk Lymphoma. 2015;56(9):2750-2. doi: 10.3109/10428194.2015.1010161. Epub 2015 Mar 6. Leuk Lymphoma. 2015. PMID: 25644745 No abstract available.
Primary uterine lymphoma: The Yokohama Cooperative Study Group for Hematology (YACHT) study.
Ishii Y, Fujisawa S, Ando T, Suzuki T, Ishiyama Y, Kishimoto K, Hattori Y, Nakajima Y, Miyazaki T, Takasaki H, Matsumoto K, Koharazawa H, Taguchi J, Fujimaki K, Sakai R, Nakajima H. Ishii Y, et al. Among authors: kishimoto k. Asia Pac J Clin Oncol. 2018 Oct;14(5):e455-e459. doi: 10.1111/ajco.13049. Epub 2018 Jul 8. Asia Pac J Clin Oncol. 2018. PMID: 29984481
721 results